Its aberrant activation and presence in NTRK3 fusion proteins induces the epithelial to mesenchymal transition program, increases the cancer cell growth rate and oncogenic capacity activating different pathways associated with tumor development and progression [64,67]. Here, NTRK3 is linked to neoplasm.